IRIS
RUCCI, NADIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.104
EU - Europa 4.811
AS - Asia 4.740
SA - Sud America 529
AF - Africa 61
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.260
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.997
SG - Singapore 1.918
CN - Cina 1.147
RU - Federazione Russa 1.034
IE - Irlanda 963
IT - Italia 604
TR - Turchia 547
DE - Germania 543
BR - Brasile 465
HK - Hong Kong 444
VN - Vietnam 405
SE - Svezia 358
GB - Regno Unito 339
UA - Ucraina 310
FR - Francia 248
FI - Finlandia 194
IN - India 79
CA - Canada 55
NL - Olanda 55
JP - Giappone 42
BD - Bangladesh 39
PL - Polonia 33
MX - Messico 30
BE - Belgio 25
AT - Austria 21
ZA - Sudafrica 21
AR - Argentina 20
ES - Italia 20
LT - Lituania 20
CZ - Repubblica Ceca 17
IQ - Iraq 14
MA - Marocco 14
KR - Corea 13
EC - Ecuador 11
PK - Pakistan 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
ID - Indonesia 10
AU - Australia 9
UZ - Uzbekistan 9
EG - Egitto 8
KE - Kenya 6
MY - Malesia 6
PY - Paraguay 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
CL - Cile 5
CO - Colombia 5
IL - Israele 5
JO - Giordania 5
DO - Repubblica Dominicana 4
PA - Panama 4
CH - Svizzera 3
DZ - Algeria 3
GR - Grecia 3
GT - Guatemala 3
KZ - Kazakistan 3
NP - Nepal 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
BG - Bulgaria 2
BO - Bolivia 2
EU - Europa 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
IS - Islanda 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 21.252
Salva come PNG Salva come JPEG
Città #
Dallas 3.256
Jacksonville 1.204
Singapore 1.135
Chandler 1.039
Dublin 961
San Jose 845
Ashburn 450
Hong Kong 437
Boardman 435
Santa Clara 409
Council Bluffs 306
Izmir 261
Nanjing 240
San Mateo 227
The Dalles 222
New York 199
L’Aquila 182
Wilmington 169
Lawrence 165
Princeton 165
Moscow 158
Beijing 129
Lauterbourg 123
Ho Chi Minh City 118
Ann Arbor 106
Hanoi 89
Milan 88
Nanchang 85
Los Angeles 71
L'aquila 67
Munich 61
Hefei 55
Shenyang 53
Seattle 49
Dong Ket 48
Rome 47
Woodbridge 47
Tianjin 44
Guangzhou 43
Bremen 42
Tokyo 41
Hebei 40
Amsterdam 37
São Paulo 37
Verona 35
Kitzingen 33
Kunming 32
Des Moines 31
Shanghai 31
Mountain View 29
Orem 29
Falkenstein 28
Jiaxing 28
Columbus 27
Warsaw 26
Norwalk 25
Brooklyn 24
Brussels 24
Chennai 24
Turku 24
Frankfurt am Main 23
Jinan 23
Helsinki 22
Montreal 21
Phoenix 20
Da Nang 19
Dearborn 19
Falls Church 19
San Francisco 19
Changsha 16
Chicago 15
Lanzhou 15
London 15
Toronto 15
Brno 14
Johannesburg 14
Mumbai 14
Ningbo 14
Zhengzhou 14
Atlanta 13
Denver 13
Houston 13
Lappeenranta 13
Pescara 13
Rio de Janeiro 13
Manchester 11
Nuremberg 11
Philadelphia 11
Poplar 11
Taizhou 11
Tappahannock 11
Ankara 10
Belo Horizonte 10
Brasília 10
Stockholm 10
Boston 9
Mexico City 9
Biên Hòa 8
Fremont 8
Hangzhou 8
Totale 14.992
Salva come PNG Salva come JPEG
Nome #
(0) Save to: more options The matrix proline/arginine-rich end leucine-rich repeat protein (PRELP) inhibits osteoclastogenesis inactivating NF-kappaB signal 3.091
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 181
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 165
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 164
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 159
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 150
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV) 149
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 149
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 145
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling 142
Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in mice 142
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS 140
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 139
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 139
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. 138
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 137
Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells 135
Bone cells and the mechanisms of bone remodelling 135
Non-conventional role of haemoglobin beta in breast malignancy 135
c-Src inhibition decreases breast cancer-induced lethality and incidence of metastases in nude mice. 135
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. 135
Ontogenesis and cell specific localization of Fas ligand expression in the rat testis 134
The unexpected role of Hemoglobin beta (HBB) in breast cancer. 134
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in chinese hamster ovary (CHO) cells 133
the effect of microgravity on osteoblast metabolism 133
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 131
The "love-hate" relationship between osteoclasts and bone matrix 131
Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis 129
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 128
Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy 128
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 127
Apoptosi e spermatogenesi: implicazioni fisiopatologiche 127
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice 126
Transcriptomic and bioinformatic analysis of Clcn7-dependent Autosomal Dominant Osteopetrosis type 2. Preclinical and clinical implications 126
RNA methylation and cellular response to oxidative stress-promoting anticancer agents 125
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 125
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 125
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 125
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 125
Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident Cells 124
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 123
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 123
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 123
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 123
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 122
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 120
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 120
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 120
Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women 120
Individualized Whole-Body Vibration: Neuromuscular, Biochemical, Muscle Damage and Inflammatory Acute Responses 119
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 118
Tyrosine kinase Src inhibitors: Cellular mechanisms for potential therapeutic applications in bone disease. 118
In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human cancer cells 118
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 118
C-SRC inhibition decreases breast cancer-induced lethality and incidence of experimental bone metastases in Balb nu/nu mice 117
The "soft" side of the bone: unveiling its endocrine functions. 117
Extracellular Vesicles in Bone Tumors: How to Seed in the Surroundings Molecular Information for Malignant Transformation and Progression 116
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway 115
Imbalance of osteoclastogenesis-regulating factors in celiac disease 115
c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation 115
Apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis 115
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 114
Switching homes: how cancer moves to bone 114
Osteoblast-derived extracellular vesicles influence MNNG/HOS osteosarcoma cells, reducing their migration and affecting their metabolic activity and redox balance 113
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 112
A six-gene signature predicting breast cancer lung metastasis 112
c-Src inhibition as a possible therapy against human breast cancer and bone metastases. 111
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio 110
Role of estrogen receptor alpha in aggressiveness and osteoclastogenic potential of human breast carcinoma cells. 109
Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma 109
A new heterozygous mutation (R714C) of the osteopetrosis gene, Pleckstrin Homolog Domain Containing Family M (With Run Domain) Member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts 109
Bone metastasis pain, from the bench to the bedside 108
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 108
HistoEnder: a 3D printer-based histological slide autostainer that retains 3D printer functions 107
A model for in vitro three dimensional cultures of osteoblast-like cells 107
Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology 107
Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework‐8 Nanoparticles 106
Editorial: Extracellular vesicles as modulators of cancer cell adaptive responses linked to therapy resistance 106
Thyroid hormone effects on mouse oocyte maturation and granulosa cell aromatase activity 106
Impaired skeletal development in interleukin-6 transgenic mice. A model for the impact of chronic inflammation on the growing skeletal system 105
Osteoclast receptors and signaling 105
How the "seed" prepares the "soil": The bone/bone marrow pre-metastatic niche 105
Cytokine imbalance in Celiac disease and parallel direct stimulation of osteoclastogenesis and osteoblast activity in vitro. 103
inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases 103
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 102
EFFECTS OF DUAL PI3K AND mTOR INHIBITION ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 101
The matrix PROLINE/Arginine-Rich end leucin-rich repeat protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity 101
Alternative TrkA splicing and Cancer 100
Microgravity induces apoptosis and increases interleukin 6 expression in osteoblast-like cells. 100
Circulating Extracellular Vesicles Express Receptor Activator of Nuclear Factor κB Ligand and Other Molecules Informative of the Bone Metabolic Status of Mouse Models of Experimentally Induced Osteoporosis 100
Osteomimicry: how tumor cells try to deceive the bone 99
Effectiveness Of Osteotropic Nanoparticles On Bone Metastases 99
Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and –beta during human testicular development and disease 98
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice 98
A Combined Fc-OPG/hPTH(1-34) Therapy to Restore Impaired Skeletal Growth and Bone Loss in a Mouse Model of IL-6 Dependent Juvenile Inflammatory Diseases 98
Thyroid hormone modulation of aromatase activity and expression in mouse granulosa cells 97
Tumour-derived extracellular vesicles (EVs): A dangerous “message in a bottle” for bone 97
Bone and bone marrow: the same organ 96
Osteoblast and osteocyte: games without frontiers 96
Regulatory loops involving IGFBP5 account for a fine tuning regulation of osteoblast and osteoclast activity in the context of the IL-6 pathway 95
Totale 15.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 0 0 0 0 0 0 84
2021/2022916 44 96 136 58 38 25 20 61 70 22 79 267
2022/20232.962 202 143 29 323 315 331 12 214 1.236 21 86 50
2023/2024928 228 55 42 119 69 212 7 43 4 25 16 108
2024/20253.022 54 48 291 145 397 290 386 275 590 159 224 163
2025/20268.946 344 1.030 2.509 904 514 499 1.083 225 519 778 458 83
Totale 21.411